BrainsWay Ltd. (TLV:BWAY)
1,712.00
+19.00 (1.12%)
Apr 1, 2025, 4:47 PM IDT
BrainsWay Revenue
In the year 2024, BrainsWay had annual revenue of $41.02M USD with 29.04% growth. BrainsWay had revenue of $11.41M in the quarter ending December 31, 2024, with 26.41% growth.
Revenue
$41.02M
Revenue Growth
+29.04%
P/S Ratio
3.68
Revenue / Employee
$306.09K
Employees
134
Market Cap
637.11M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.02M | 9.23M | 29.04% |
Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 60.26B |
Danel (Adir Yeoshua) | 2.77B |
Kamada | 586.24M |
Bait Bakfar | 103.40M |
Novolog (Pharm-Up 1966) | 2.02B |
Ilex Medical | 982.96M |
SofWave Medical | 217.27M |
Golden House | 47.96M |
BrainsWay News
- 21 days ago - BrainsWay Ltd. (BWAY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - BrainsWay GAAP EPS of $0.04 beats by $0.02, revenue of $11.41M beats by $0.52M - Seeking Alpha
- 21 days ago - BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 21 days ago - Earnings Scheduled For March 11, 2025 - Benzinga
- 22 days ago - BrainsWay Q4 2024 Earnings Preview - Seeking Alpha
- 3 months ago - BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder - GlobeNewsWire
- 4 months ago - BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy - GlobeNewsWire
- 4 months ago - BrainsWay: Cash Flow Doubts Weigh On The Stock - Seeking Alpha